
|Articles|November 1, 2022
Origins Insights Announces Transition to Patient Specialist Agency
Deeper focus on patient engagement across the pharma/biotech product lifecycle.
Advertisement
Origins Insights, a Resonant Group company, announced the evolution of its service offering to become an exclusively patient focused agency.
Origins evolved service offering is built around a four-step process moving through strategy development, insight generation, patient experience data collation, and solutions designed to optimize the patient voice.
Read more about the transition
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
What Kinds of Disruption are GLP-1s Expected to Face
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
Director of NIH Infectious Disease Institute Steps Down
5




